模仿克朗氏病的循环性中性症:两个病例报告和叙述性审查
Alessia Dalila Guarino1, Gaetano Luglio2, Nicola Imperatore3
1Gastroenterology, Department of Clinical Medicine and Surgery, "Federico II" University, 80131 Naples, Italy.
Journal of clinical medicine
|October 14, 2023
概括
循环性中性质疏松症是一种罕见的血液疾病,伴有复发性感染和口腔. 颗粒细胞殖民地刺激因子 (G-CSF) 有效地治疗这种疾病,强调了准确诊断的重要性,特别是当与炎症性肠道疾病同时发生时.
科学领域:
- 血液学 血液学 血液学
- 胃肠病学 胃肠病学
- 罕见疾病 罕见疾病
背景情况:
- 循环性中性缺血症是一种罕见的血液学疾病,周期为21天,导致经常性感染,发烧和口腔.
- 炎症性肠病 (IBD),包括克罗恩病 (CD) 和性结肠炎 (UC),是经常在年轻人中诊断出的慢性胃肠道疾病.
- 错误的诊断可能是由于重叠的症状,如循环中性病和IBD之间的复发性感染和口腔.
研究的目的:
- 报告两例最初被诊断患有复杂克罗恩病的患者.
- 为了突出这些患者随后的循环中性质的诊断.
- 强调差异诊断在管理患有重叠的血液学和胃肠道疾病的患者中的关键作用.
主要方法:
- 两名患者的病例报告分析.
- 对于复杂的克罗恩病进行手术干预.
- 血液学咨询和诊断周期性中性衰竭.
- 开始用花细胞殖民地刺激因子 (G-CSF) 治疗.
主要成果:
- 两位患者都呈现出暗示复杂克罗恩病的症状,导致手术干预.
- 手术后,确定了持续性中性质疏松症,从而诊断出循环中性质疏松症.
- 启动了G-CSF治疗,从而改善了临床结果,并减少了中性质衰竭的持续时间.
结论:
- 循环性中性不良症可能是IBD的同时出现的疾病,需要仔细的差异诊断.
- 早期和准确的诊断周期性中性质衰竭对于有效的管理至关重要.
- G-CSF疗法在治疗周期性中性质衰竭方面提供了显著的好处,改善了患者的预后.
关键词:
克罗恩氏病是什么 克罗恩氏病是什么IBD IBD IBD IBD IBD IBD IBD IBD IBD IBD IBD IBD IBD IBD IBD循环性中性质衰竭 (Cyclic Neutropenia) 是一种周期性的中性质衰竭.患有白血病的病例包括白血病.手术 手术 手术 手术 手术 手术 手术更多相关视频
相关概念视频
Inflammatory Bowel Disease II: Crohn's Disease
264
Introduction
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
264
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
173
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
173
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
339
Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
339
Chronic Bowel Disorders: Introduction
460
Chronic bowel diseases are a group of long-term conditions affecting the digestive tract, characterized by inflammation and damage to the gut lining. These conditions primarily include irritable bowel syndrome and inflammatory bowel disease.
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
460
Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
150
Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab...
150
Inflammatory Bowel Disease I: Ulcerative Colitis
196
Introduction
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
196


